Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

about

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging

P2860

Q58743469-E6EB3706-D98E-496B-9C99-3CD8289935B7

P2860

Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

Item

http://www.wikidata.org/entity/Q50091464

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@en

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@nl

type

Item

label

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@en

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@nl

prefLabel

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@en

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@nl

P1476

Inhibition of Small-Conductanc ...... herapy of Atrial Fibrillation?

@en

P2093

Dobromir Dobrev

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation

Small and intermediate conductance Ca(2+)-activated K+ channels confer distinctive patterns of distribution in human tissues and differential cellular localisation in the colon and corpus cavernosum.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites

The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis

Proarrhythmic effect of blocking the small conductance calcium activated potassium channel in isolated canine left atrium.

Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression.

Novel K+ Channel Targets in Atrial Fibrillation Drug Development--Where Are We?

P31

scholarly article

editorial

P356

10.1161/CIRCEP.117.005776

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jordi Heijman

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29018167

http://www.w3.org/2001/XMLSchema#string

P932

5646693

http://www.w3.org/2001/XMLSchema#string

Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

about

P2860

P2860

Inhibition of Small-Conductance Ca2+-Activated K+ Channels: The Long-Awaited Breakthrough for Antiarrhythmic Drug Therapy of Atrial Fibrillation?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P433

P478

P50

P577

P698

P932